Glythera Limited
Dormant Company · Newcastle Upon Tyne
ActiveUnited KingdomIncorporated 2018Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-12-31
Scanned accounts · read by AI
AI-read
Accounts to 2025-12-31
Scanned accounts · read by AI
- Accounts to
- 2025-12-31
- Filed
- Accounts
- How we read it
- These were filed as scanned pages, so the figures were read by AI and small errors are possible.
Accounts to 2021-05-31
IXBRL · 29 source facts · 4 selected values
Not assessedlegacy record
Accounts to 2021-05-31
IXBRL · 29 source facts · 4 selected values
Not assessed
legacy record
- Reporting period
- 2020-06-01 to 2021-05-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 8
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0093_11380673_20210531
- Source archive
- Accounts_Monthly_Data-August2021.zip
Registered details
11380673- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2018-05-24
- Jurisdiction
- —
- Registered office
- THE BIOSPHERE, DRAYMANS WAY, NEWCASTLE UPON TYNE, NE4 5BX, UNITED KINGDOM
Classification
1 SIC codes99999
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
5 matched grantsModify-catch-release-repeat: Reversible bioconjugations for controlled release of small molecules from antibodies and their fragmentsEPSRC · Research Grant · 2019-01-01 – 2023-03-30 · with 1 other participant£414,878whole project
Modify-catch-release-repeat: Reversible bioconjugations for controlled release of small molecules from antibodies and their fragments
EPSRC · Research Grant · 2019-01-01 – 2023-03-30 · with 1 other participant
£414,878
whole project
University Of YorkleadGlythera Ltd
Optimisation of sortase-mediated protein labelling as a tool for biotechnology and pharmaceutical developmentBBSRC · Research Grant · 2018-04-03 – 2019-10-02 · with 1 other participant£212,173whole project
Optimisation of sortase-mediated protein labelling as a tool for biotechnology and pharmaceutical development
BBSRC · Research Grant · 2018-04-03 – 2019-10-02 · with 1 other participant
£212,173
whole project
University of LeedsleadGlythera Ltd
Developing & Testing 2nd Generation Oncology Focused Potent & Bioselective PermaLink-derived ADCsCOVID · Studentship · 2017-09-30 – 2021-12-31 · with 1 other participant£0whole project
Developing & Testing 2nd Generation Oncology Focused Potent & Bioselective PermaLink-derived ADCs
COVID · Studentship · 2017-09-30 – 2021-12-31 · with 1 other participant
£0
whole project
University Of East AnglialeadGlythera Ltd
Bioprocessing Network: BioProNETBBSRC · Research Grant · 2014-03-01 – 2019-08-30 · with 63 other participants£1,771,629whole project
Bioprocessing Network: BioProNET
BBSRC · Research Grant · 2014-03-01 – 2019-08-30 · with 63 other participants
£1,771,629
whole project
University Of KentleadAccelyo LtdActavisAlgaecytes LimitedArecorAstrazenecaAustrian Centre for Applied BiotechnologyBath ASUBiopro Control Tech LimitedBioServeBio-Shape LtdCentre for Process Innovation (CPI)Cobra BiologicsCovance Clinical And Periapproval Services LimitedCroda Europe LtdCrystec PharmaDelft University of Technology (TU Delft)Durham UniversityFujifilmGlaxoSmithKline (GSK)Glythera LtdHyaltechImperial College LondonJeol UK LtdJohns Hopkins UniversityJohnson MattheyKnowledge Transfer NetworkLancaster UniversityLonza GroupLoughborough UniversityMicroSynbiotiXMologicMRC-TechnologyNovo NordiskOxford Nanopore TechnologiesPall Life SciencesPlymouth Marine LaboratoryProtein ArkProtein Technologies LtdPublic Health EnglandRecipharmRecyclatech Group LtdSAL ScientificSanofiSwansea UniversityTeesside UniversityTotalLab LtdUCB PharmaUcb SAUniversity College LondonUniversity College OxfordUniversity of AberdeenUniversity of BathUniversity Of BirminghamUniversity of CambridgeUniversity Of EdinburghUniversity of KentUniversity of LeedsUniversity Of ManchesterUniversity Of NottinghamUniversity of SheffieldUniversity of WarwickUniversity Of YorkVaricon Aqua Solutions Ltd
Defining the role of aberrant O-linked glycosylation in breast cancerMRC · Research Grant · 2012-11-01 – 2016-01-31 · with 6 other participants£480,719whole project
Defining the role of aberrant O-linked glycosylation in breast cancer
MRC · Research Grant · 2012-11-01 – 2016-01-31 · with 6 other participants
£480,719
whole project
King'S College LondonleadCornell UniversityGlythera LtdImperial College LondonKing’s Health PartnersPalleon Pharmaceuticals IncUniversity Of Birmingham